Neurotoxic study of H2 antagonists using Xenopus oocytes injected with mouse-brain mRNA

Biological and Pharmaceutical Bulletin

Volumn 20, Issue 9, 1997, Pages 1030-1032

  Kawakami, Junichi ^a   Yamamoto, Koujirou ^a   Shimokawa, Masafumi ^a   Sawada, Yasufumi ^a,c   Asanuma, Atsushi ^b   Yanagisawa, Keiji ^b   Iga, Tatsuji ^a  

^a UNIVERSITY OF TOKYO HOSPITAL   (Japan)

^b TSURUMI UNIVERSITY   (Japan)

^c KYUSHU UNIVERSITY   (Japan)

Author keywords

Convulsion; H2 antagonist; MRNA; Screening; Xenopus oocyte; aminobutyric acid (GABA)

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR; CIMETIDINE; FAMOTIDINE; GLUTAMIC ACID; GLYCINE; HISTAMINE H2 RECEPTOR ANTAGONIST; N METHYL DEXTRO ASPARTIC ACID; NIZATIDINE; RANITIDINE; SEROTONIN; MESSENGER RNA; NEUROTOXIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CEREBROSPINAL FLUID ANALYSIS; CONVULSION; DRUG EFFECT; DRUG POTENCY; MALE; MOUSE; NEUROTOXICITY; NEUROTRANSMISSION; NONHUMAN; OOCYTE; RNA ANALYSIS; XENOPUS; ANIMAL; BIOSYNTHESIS; BRAIN LEVEL; MICROINJECTION; PATCH CLAMP; PHYSIOLOGY;

ANIMALS; BRAIN CHEMISTRY; CIMETIDINE; HISTAMINE H2 ANTAGONISTS; MALE; MICE; MICROINJECTIONS; NEUROTOXINS; OOCYTES; PATCH-CLAMP TECHNIQUES; RNA, MESSENGER; XENOPUS;

EID: 0030611650     PISSN: 09186158     EISSN: None     Source Type: Journal    
DOI: 10.1248/bpb.20.1030     Document Type: Article

References (13)

1. Sawyer D., Conner C. S., Scalley R., Am. J. Hosp. Pharm., 38, 188-197 (1981).
2. Cantú T. G., Korek J. S., Ann. Intern. Med., 114, 1027-1034 (1991).
3. Juergens J.P., Smith I. S., Post Marketing Surveillance, 5, 135-144 (1991).
4. Slugg P. H., Haug M. T., Pippenger C. E., Arch. Intern. Med., 152, 2325-2329 (1992).
5. Shimokawa M., Yamamoto K., Kawakami J., Sawada Y., Iga T., Toxicol. Appl. Pharmacol., 136, 317-323 (1996).
6. Horikoshi T., Asanuma A., Yanagisawa K., Anzai K., Goto S., Mol. Brain Res., 4, 97-105 (1988).
7. Kawakami J., Shimokawa M., Yamamoto K., Sawada Y., Asanuma A., Yanagisawa K., Iga T., Biol. Pharm. Bull., 16, 726-728 (1993).
8. Kawakami J., Yamamoto K., Asanuma A., Yanagisawa K., Sawada Y., Iga T., Toxicol Appl. Pharmacol., 145, 246-254 (1997).
9. Aoshima H., Anan M., Ishii H., Iio H., Kobayashi S., Biochemistry, 26, 4811-4816 (1987).
10. Asanuma A., Horikoshi T., Yanagisawa K., Anzai K., Goto S., Neurosci. Lett., 76, 87-90 (1987).
11. Speeg K. V., Wang S., Avant G. R., Parker R., Schenker S., J. Lab. Clin. Med., 97, 112-122 (1981).
12. Lakoski J. M., Aghajanian G. K., Gallager D. W., Eur. J. Pharmacol., 8, 241-245 (1983).
13. Edmonds M. E., Ashford R. F. U., J. Roy. Soc. Med., 72, 172-175 (1979).